Nanovector-based prolyl hydroxylase domain 2 silencing system enhances the efficiency of stem cell transplantation for infarcted myocardium repair

References

• PtaszekLMMansourMRuskinJNTowards regenerative therapy for cardiac diseaseLancet2012379981993394222405796
   PubMed Web of Science ®Google Scholar
• NakamuraYWangXXuCXenotransplantation of long-term-cultured swine bone marrow-derived mesenchymal stem cellsStem Cells200725361262017095707
   PubMed Web of Science ®Google Scholar
• PennMSMangiAAGenetic enhancement of stem cell engraftment, survival, and efficacyCirc Res2008102121471148218566313
   PubMed Web of Science ®Google Scholar
• TerrovitisJVSmithRRMarbánEAssessment and optimization of cell engraftment after transplantation into the heartCirc Res2010106347949420167944
   PubMed Web of Science ®Google Scholar
• TongersJLosordoDWLandmesserUStem and progenitor cell-based therapy in ischaemic heart disease: promise, uncertainties, and challengesEur Heart J201132101197120621362705
   PubMed Web of Science ®Google Scholar
• HuangJZhangZGuoJGenetic modification of mesenchymal stem cells overexpressing CCR1 increases cell viability, migration, engraftment, and capillary density in the injured myocardiumCirc Res2010106111753176220378860
   PubMed Web of Science ®Google Scholar
• TaylorCTInterdependent roles for hypoxia inducible factor and nuclear factor-kappaB in hypoxic inflammationJ Physiol2008586Pt 174055405918599532
   PubMed Web of Science ®Google Scholar
• BerraEBenizriEGinouvèsAHIF prolyl-hydroxylase 2 is the key oxygen sensor setting low steady-state levels of HIF-1alpha in normoxiaEMBO J200322164082409012912907
   PubMed Web of Science ®Google Scholar
• HuangMNguyenPJiaFDouble knockdown of prolyl hydroxylase and factor-inhibiting hypoxia-inducible factor with nonviral minicircle gene therapy enhances stem cell mobilization and angiogenesis after myocardial infarctionCirculation201112411 SupplS46S5421911818
   PubMed Web of Science ®Google Scholar
• HoWangYinKYLoinardCBakkerWHIF-prolyl hydroxylase 2 inhibition enhances the efficiency of mesenchymal stem cell-based therapies for the treatment of critical limb ischemiaStem Cells201432123124324105925
   PubMed Web of Science ®Google Scholar
• WangWEYangDLiLProlyl hydroxylase domain protein 2 silencing enhances the survival and paracrine function of transplanted adipose-derived stem cells in infarcted myocardiumCirc Res2013113328830023694817
   PubMed Web of Science ®Google Scholar
• AlabiCVegasAAndersonDAttacking the genome: emerging siRNA nanocarriers from concept to clinicCurr Opin Pharmacol201212442743322726555
   PubMed Web of Science ®Google Scholar
• ShenHSunTFerrariMNanovector delivery of siRNA for cancer therapyCancer Gene Ther201219636737322555511
   PubMed Web of Science ®Google Scholar
• TanSJKiatwuthinonPRohYHEngineering nanocarriers for siRNA deliverySmall20117784185621374801
   PubMed Web of Science ®Google Scholar
• RavinaMPaolicelliPSeijoBKnocking down gene expression with dendritic vectorsMini Rev Med Chem2010101738620380642
   PubMed Web of Science ®Google Scholar
• ContiDSBrewerDGrashikJPoly(amidoamine) dendrimer nanocarriers and their aerosol formulations for siRNA delivery to the lung epitheliumMol Pharm20141161808182224811243
   PubMedGoogle Scholar
• ShcharbinDShakhbazauABryszewskaMPoly(amidoamine) dendrimer complexes as a platform for gene deliveryExpert Opin Drug Deliv201310121687169824168461
   PubMed Web of Science ®Google Scholar
• LiuCLiuXRocchiPArginine-terminated generation 4 PAMAM dendrimer as an effective nanovector for functional siRNA delivery in vitro and in vivoBioconjug Chem201425352153224494983
   PubMed Web of Science ®Google Scholar
• KimTIBaiCZNamKComparison between arginine conjugated PAMAM dendrimers with structural diversity for gene delivery systemsJ Control Release2009136213213919331841
   PubMed Web of Science ®Google Scholar
• BaiCZChoiSNamKArginine modified PAMAM dendrimer for interferon beta gene delivery to malignant gliomaInt J Pharm20134451–2798723384727
   PubMedGoogle Scholar
• ZhuKLaiHGuoCNovel vascular endothelial growth factor gene delivery system-manipulated mesenchymal stem cells repair infarcted myocardiumExp Biol Med20122376678687
   Web of Science ®Google Scholar
• DingYWangWFengMA biomimetic nanovector-mediated targeted cholesterol-conjugated siRNA delivery for tumor gene therapyBiomaterials201233348893890522979990
   PubMed Web of Science ®Google Scholar
• ShiLWangLWangBRegulatory mechanisms of betacellulin in CXCL8 production from lung cancer cellsJ Transl Med2014127024629040
   PubMed Web of Science ®Google Scholar
• ZhuKGuoCXiaYTransplantation of novel vascular endothelial growth factor gene delivery system manipulated skeletal myoblasts promote myocardial repairInt J Cardiol201316832622263123578891
   PubMed Web of Science ®Google Scholar
• TangYLiYBWangBEfficient in vitro siRNA delivery and intramuscular gene silencing using PEG-modified PAMAM dendrimersMol Pharm2012961812182122548294
   PubMedGoogle Scholar
• NamHYMcGinnAKimPHPrimary cardiomyocyte-targeted bioreducible polymer for efficient gene delivery to the myocardiumBiomaterials201031318081808720674007
   PubMed Web of Science ®Google Scholar
• SongLChauLSakamotoYElectric field-induced molecular vibration for noninvasive, high-efficiency DNA transfectionMol Ther20049460761615093191
   PubMed Web of Science ®Google Scholar
• MoonHHJooMKMokHMSC-based VEGF gene therapy in rat myocardial infarction model using facial amphipathic bile acid-conjugated polyethyleneimineBiomaterials20143551744175424280192
   PubMed Web of Science ®Google Scholar
• MaDEnhancing endosomal escape for nanoparticle mediated siRNA deliveryNanoscale20146126415642524837409
   PubMed Web of Science ®Google Scholar
• HuangXPallaoroABraunGBModular plasmonic nanocarriers for efficient and targeted delivery of cancer-therapeutic siRNANano Lett20141442046205124597503
   PubMed Web of Science ®Google Scholar
• PosoccoPLiuXLauriniEImpact of siRNA overhangs for dendrimer-mediated siRNA delivery and gene silencingMol Pharm20131083262327323841848
   PubMedGoogle Scholar
• MarinEBriceñoMICaballero-GeorgeCCritical evaluation of biodegradable polymers used in nanodrugsInt J Nanomedicine201383071309023990720
   PubMed Web of Science ®Google Scholar
• LoinardCGinouvesAVilarJInhibition of prolyl hydroxylase domain proteins promotes therapeutic revascularizationCirculation20091201505919546390
   PubMed Web of Science ®Google Scholar